PDF下载 ( 1137 KB)
Correlation of ALT, HBV DNA, and serum markers of fibrosis with liver fibrosis in patients with chronic hepatitis B
-
摘要: 目的探讨ALT、HBV DNA以及血清纤维化标志物透明质酸（HA）、层粘连蛋白（LN）、Ⅲ型前胶原肽（PⅢP）、Ⅳ型胶原（CⅣ）与慢性乙型肝炎肝纤维化程度的关系。方法检测281例慢性乙型肝炎患者血清中ALT、HBV DNA和纤维化标志物（HA、LN、PⅢP及CⅣ）的水平,并行肝活检检测肝组织病理纤维化分期。结果 HBeAg阴性慢性乙型肝炎患者HBV DNA水平较低、纤维化程度较高。HBeAg阳性患者纤维化程度与HBV DNA呈负相关（r=-0.251,P<0.001）,S≥3组水平最低。慢性乙型肝炎患者纤维化程度与PⅢP水平呈正相关,其水平随着纤维化程度的加重而明显升高。结论 PⅢP水平可能作为评估慢性乙型肝炎患者肝纤维化程度的血清学指标,血清HBV DNA与肝脏纤维化严重程度的关系仍需进一步深入探讨。Abstract: Objective To investigate the relationship between levels of alanine aminotransferase (ALT) , hepatitis B virus (HBV) DNA, hepatitis B virus e antigen (HBeAg) , and serum fibrosis markers [ (hyaluronic acid (HA) , laminin (LN) , type Ⅲ procollagen (PⅢP) , and type IV collagen (CIV) ] and severity of liver fibrosis in patients with chronic hepatitis B (CHB) .Methods A total of 218 CHB patients were included in this study.Serum levels of ALT were measured by standard biochemical assay.HBV DNA was measured by quantitative PCR.Fibrosis markers (HA, LN, PⅢP, and CIV) were measured by radioimmunoassay.The severity of liver fibrosis was determined by histopathological examination of liver biopsy.Results HBeAg (-) CHB patients had a lower level of HBV DNA and a higher level of fibrosis than HBeAg (+) CHB patients.Liver fibrosis in the HBeAg (+) CHB patients was negatively correlated with HBV DNA level (r=-0.251, P<0.001) , and the lowest level was found in patients with fibrosis stages ≥3.The severity of liver fibrosis in CHB patients was positively correlated with the serum levels of PⅢP, which continued to increase with severity during progressive development of liver fibrosis.Conclusion Levels of PⅢP may represent a useful serum marker of liver fibrosis severity.The relationship between HBV DNA and liver fibrosis requires further study for confirmation.
-
Key words:
- hepatitis B /
- chronic /
- liver cirrhosis /
- alanine transaminase
-
[1] 中华医学会肝病学分会, 感染病学分会.慢性乙型肝炎防治指南 (2010年版) [J].临床肝胆病杂志, 2011, 27 (1) :1-16. [2]Chen YC, Chu CM, Yeh CT, et al.Natural course followingthe onset of cirrhosis in patients with chronic hepatitis B:along-term follow-up study[J].Hepatol Int, 2007, 1 (1) :267-273. [3]中华医学会传染病与寄生虫病分会、肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) :324-329. [4]European Association For The Study Of The Liver.EASL Clin-ical Practice Guidelines:Management of chronic hepatitis Bvirus infection[J].J Hepatol, 2012 Mar 20.[Epub aheadof print] [5] 陆传统, 周文红, 胡爱荣.HBeAg阴性慢性乙型肝炎患者血清病毒载量与肝组织学改变的关系[J].中华实验和临床病毒学杂志, 2010, 24 (3) :184-186. [6]郑自华, 张立伐, 陈友鹏, 等.HBeAg阴性慢性乙型肝炎病毒载量与肝损害的关系[J].暨南大学学报 (医学版) , 2008, 29 (2) :184. [7]Chen CF, Lee WC, Yang HI, et al.Risk Evaluation of ViralLoad Elevation and Associated Liver Disease/Cancer in HBV (REVEAL–HBV) Study Group.Changes in serum levels ofHBV DNA and alanine aminotransferase determine risk forhepatocellular carcinoma[J].Gastroenterology, 2011, 141 (4) :1240-1248. [8]Iloeje UH, Yang HI, Su J, et al.Predicting cirrhosis risk basedon the level of circulating hepatitis B viral load[J].Gastroenter-ology, 2006, 130 (3) :678-686. [9]Seto WK, Lai CL, Ip PP, et al.A large population histologystudy showing the lack of association between ALT elevationand significant fibrosis in chronic hepatitis B[J].PLoS One, 2012, 7 (2) :e32622. [10]Chan HL, Tsang SW, Liew CT, et al.Viral genotype and hepati-tis B virus DNA levels are correlated with histological liver dam-age in HBeAg-negative chronic hepatitis B virus infection[J].Am J Gastroenterol, 2002, 97 (2) :406-412. [11]柯柳, 温小凤, 蒋忠胜, 等.慢性肝炎患者乙型肝炎病毒复制与肝纤维化程度的关系[J].广东医学, 2010, 31 (5) :628-629. [12]Shao J, Wei L, Wang H, et al.Relationships between hepa-titis B virus DNA levels and liver histology in patients withchronic hepatitis B[J].World J Gastroenterol, 2007, 13 (14) :2104-2107. [13]陆伦根, 曾民德.肝纤维化非创伤性诊断研究进展[J].中华医学杂志, 2005, 85 (15) :1078-1080. [14]郑利平, 潘爱萍.乙肝患者血清学标志物与肝纤维化的关系[J].广东医学, 2008, 29 (7) :1143-1145. -
本文二维码
计量
- 文章访问数: 3746
- HTML全文浏览量: 12
- PDF下载量: 855
- 被引次数: 0
下载:
